Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Allergan.

Community Practice Connections™ Coffee Talk: Initiating Early Recognition and Intervention in a Rare Lymphoma Associated with Breast Implants

Release Date: April 28, 2020
Expiration Date: April 28, 2021

Activity Overview

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma and is a distinct entity from systemic ALCL. In the United States, the FDA began to recognize reports of ALCL and a potential association with breast implants in 2011, and subsequently started a collaboration with the American Society of Plastic Surgeons (ASPS) and the Plastic Surgery Foundation (PSF) to create the Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma (ALCL) Etiology and Epidemiology (PROFILE Registry). Incidence has been associated with the textured surface of the implant and is highest in the more highly textured (ie, greater surface area) implants. Reports indicate that the majority of cases, if diagnosed quickly, are limited to effusion around the implant and can frequently be effectively treated with surgical intervention without the need for adjuvant systemic therapy. However, given the recent history of BIA-ALCL and the infrequency of incidence, physicians who see patients at first presentation of disease are unlikely to be familiar with symptoms.

This Community Practice Connection™ program is designed to assist clinicians in keeping up to date on developments in the recently defined malignancy BIA-ALCL. This online program will provide a comprehensive review of BIA-ALCL, including epidemiology, presentation, diagnosis, and treatment strategies. Integrated expert video interviews will highlight the practical application of recent data that directly influence treatment guidelines and best practices to help you provide optimal care to your patients.

Acknowledgement of Support

This activity is supported by an educational grant from Allergan.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This education activity is directed towards OB-GYNs, medical oncologists, surgical oncologists, radiation oncologists, primary care physicians, such as family practitioners and internists, and radiologists.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Describe presenting symptoms of BIA-ALCL and how to distinguish this cancer from other breast implant problems
  • Discuss the incidence and prevalence of BIA-ALCL and the need for centralized reporting
  • Identify best practices in BIA-ALCL treatment and discuss evidence available for treatment options
  • Detail a treatment strategy that incorporates a multidisciplinary team to optimize outcomes for patients with BIA-ALCL

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Lloyd B. Gayle, MD, FACS
Lloyd B. Gayle, MD, FACS
Chief of Plastic Surgery and Vice Chair of Surgery
Maimonides Medical Center
Clinical Associate Professor of Surgery
Weill Medical College of Cornell University
New York, NY

Disclosures: Lloyd B. Gayle, MD, FACS, has no relevant financial relationships with commercial interests to disclose.

Peter G. Cordeiro, MD, FACS
Peter G. Cordeiro, MD, FACS
Reconstructive Surgeon
William G. Cahan Chair in Surgery
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures: Peter G. Cordeiro, MD, FACS, has no relevant financial relationships with commercial interests to disclose.

Martin C. Mahoney, MD, PhD
Martin C. Mahoney, MD, PhD
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, NY

Disclosures: Martin C. Mahoney, MD, PhD, has no relevant financial relationships with commercial interests to disclose.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By